抄録
The effects of roxithromycin, a new orally semisynthetic macrolide, were investigated on human neutrophil chemotaxis and phagocytosis in vitro. The agent markedly stimulated neutrophil chemotaxis and phagocytosis in a dose-dependent manner. These results may indicate that roxith-romycin potentiates the activation of neutrophils in vivo.
